(2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide

C52H67N7O11 — CID 170208027

IUPAC(2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide
SMILESC[C@@H](OCc1ccc(CCCNC(=O)COCCOCCOCCCc2ccc3c(c2)n(C)c(=O)n3C2CCC(=O)N(C)C2=O)cc1)[C@H](CCC(N)=O)NC(=O)[C@@H]1Cc2cccc3c2N1C(=O)CCC3
InChIInChI=1S/C52H67N7O11/c1-34(40(19-22-45(53)60)55-50(64)44-31-39-12-4-10-38-11-5-13-48(63)59(44)49(38)39)70-32-37-16-14-35(15-17-37)8-6-24-54-46(61)33-69-29-28-68-27-26-67-25-7-9-36-18-20-41-43(30-36)56(2)52(66)58(41)42-21-23-47(62)57(3)51(42)65/h4,10,12,14-18,20,30,34,40,42,44H,5-9,11,13,19,21-29,31-33H2,1-3H3,(H2,53,60)(H,54,61)(H,55,64)/t34-,40+,42?,44+/m1/s1
InChIKeyVRNIFWITUCDQHO-QAIZDGQQSA-N
MW966.15 g/mol
LogP3.34
Rot. Bonds26

About (2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide

(2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide (PubChem CID 170208027) has the molecular formula C52H67N7O11 and a molecular weight of 966.15 g/mol. Its IUPAC name is (2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide.

Molecular Properties

Compound Name(2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide
PubChem CID170208027
Molecular FormulaC52H67N7O11
Molecular Weight966.15 g/mol
Exact Mass965.49
IUPAC Name(2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide
SMILESC[C@@H](OCc1ccc(CCCNC(=O)COCCOCCOCCCc2ccc3c(c2)n(C)c(=O)n3C2CCC(=O)N(C)C2=O)cc1)[C@H](CCC(N)=O)NC(=O)[C@@H]1Cc2cccc3c2N1C(=O)CCC3
InChIInChI=1S/C52H67N7O11/c1-34(40(19-22-45(53)60)55-50(64)44-31-39-12-4-10-38-11-5-13-48(63)59(44)49(38)39)70-32-37-16-14-35(15-17-37)8-6-24-54-46(61)33-69-29-28-68-27-26-67-25-7-9-36-18-20-41-43(30-36)56(2)52(66)58(41)42-21-23-47(62)57(3)51(42)65/h4,10,12,14-18,20,30,34,40,42,44H,5-9,11,13,19,21-29,31-33H2,1-3H3,(H2,53,60)(H,54,61)(H,55,64)/t34-,40+,42?,44+/m1/s1
InChIKeyVRNIFWITUCDQHO-QAIZDGQQSA-N
XLogP3.34
TPSA222.83 Ų
H-Bond Donors3
H-Bond Acceptors13
Rotatable Bonds26
Heavy Atoms70
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500966.15
LogP ≤ 53.34
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze (2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide?
The IUPAC name of (2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide (CID 170208027) is (2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide.
What is the SMILES notation for (2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide?
The canonical SMILES for (2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide is C[C@@H](OCc1ccc(CCCNC(=O)COCCOCCOCCCc2ccc3c(c2)n(C)c(=O)n3C2CCC(=O)N(C)C2=O)cc1)[C@H](CCC(N)=O)NC(=O)[C@@H]1Cc2cccc3c2N1C(=O)CCC3.
What is the InChIKey of (2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide?
The InChIKey is VRNIFWITUCDQHO-QAIZDGQQSA-N. The full InChI is InChI=1S/C52H67N7O11/c1-34(40(19-22-45(53)60)55-50(64)44-31-39-12-4-10-38-11-5-13-48(63)59(44)49(38)39)70-32-37-16-14-35(15-17-37)8-6-24-54-46(61)33-69-29-28-68-27-26-67-25-7-9-36-18-20-41-43(30-36)56(2)52(66)58(41)42-21-23-47(62)57(3)51(42)65/h4,10,12,14-18,20,30,34,40,42,44H,5-9,11,13,19,21-29,31-33H2,1-3H3,(H2,53,60)(H,54,61)(H,55,64)/t34-,40+,42?,44+/m1/s1.
What are the key properties of (2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide?
(2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide has a molecular weight of 966.15 g/mol, XLogP of 3.34, 26 rotatable bonds, 3 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[(2R,3S)-6-amino-2-[[4-[3-[[2-[2-[2-[3-[3-methyl-1-(1-methyl-2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-5-yl]propoxy]ethoxy]ethoxy]acetyl]amino]propyl]phenyl]methoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide is sourced from PubChem (CID 170208027), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).